+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronary Heart Disease Diagnostic Imaging Device Market Size, Share & Trends Analysis Report by Modality (Computed Tomography, X-rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine), Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 5595798
The global coronary heart disease diagnostic imaging device market size is expected to reach USD 2.96 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030. Increase in coronary diseases and deaths associated with it calls for better and early diagnosis of the condition. Precise scan interpretation and technologically advanced equipment are the factors influencing the market growth. Various imaging modalities are useful in identifying unique aspects of coronary screening. For instance, intravascular ultrasound, X-ray angiography, and computed tomography angiography (CTCA) provide a direct evaluation and quantification of alterations in the coronary arteries. However, non-invasive techniques like single-photon computed tomography (SPECT) and positron emission tomography (PET) provide indirect information on CHD by estimating the myocardial perfusion and metabolism abnormalities that are consequent of coronary artery disease.

Technological advancement in this field had led to the development of sharp camera units consisting of gamma systems, that use semiconductor detectors of cadmium zinc telluride (CZT). This led to faster acquisition of images, reduced capture time, high image quality, and lower radiation dose (1mSv for a single injection), as compared to conventional myocardial perfusion imaging by SPECT. Further, improvements around Computed Tomography, to develop non-invasive techniques have also shown great future growth in this segment. However, economic barriers, subject literacy, and lack of medical staff hold back the implementation of such advanced techniques in real practice.

The coronary heart disease diagnostic imaging devices market saw a sharp decline in 2020, due to the outbreak of the COVID-19 pandemic. Fear of virus spread, the shift in focus on diagnosing and treating COVID-19 affected patients, reduced admission rates at hospitals for other diseases, and reduced medical staff, led to the reduction in the diagnosis of CVD. Economic setback observed by end-users also influenced the adoption of advanced techniques to effectively diagnoses coronary alterations. Further, the shutting down of manufacturing units, due to national lockdowns, halt in logistics, and reduction in salesforce also impacted the market negatively.

Coronary Heart Disease Diagnostic Imaging Devices Market Report Highlights

  • Nuclear medicine dominated the modality segment due to the ease of image interpretation and accuracy in detection.
  • Computed tomography is anticipated to experience at the fastest CAGR o vefr the forecast period, due to its advantages of early detection of even the most intricate alterations which otherwise is impossible to det4ect in the traditional SPECT technology.
  • Asia Pacific is anticipated to be growing at a significant CAGR over the forecast period owing to the increase in R&D activities and numerous resellers.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Coronary Heart Disease Diagnostic Imaging Device market include:

  • Canon
  • Esaote SPA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Koninkilijhe Phillips N.V.
  • SAMSUNG
  • Siemens Healthineers AG
  • Ziehm Imaging GmbH


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Coronary Heart Disease Diagnostic Imaging Device Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Prevalence Of Coronary Artery Diseases
3.2.1.2. Rising Adoption Of Early Diagnostic Techniques
3.2.2. Market restraint analysis
3.2.2.1. Lack of Skilled Radiologists
3.3. Coronary Heart Disease Diagnostic Imaging Device Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
Chapter 4. Coronary Heart Disease Diagnostic Imaging Device Market: Modality Estimates & Trend Analysis
4.1. Global Coronary Heart Disease Diagnostic Imaging Device Market: Modality Dashboard
4.2. Global Coronary Heart Disease Diagnostic Imaging Device Market: Modality Movement Analysis
4.3. Global Coronary Heart Disease Diagnostic Imaging Device Market by Modality, Revenue
4.4. Computed Tomography
4.4.1. Computed Tomography market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. X rays
4.5.1. X rays market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Ultrasound
4.6.1. Ultrasound market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Magnetic Resonance Imaging
4.7.1. Magnetic Resonance Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Nuclear Medicine
4.8.1. Nuclear Medicine market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Coronary Heart Disease Diagnostic Imaging Device Market: Regional Estimates & Trend Analysis by Modality
5.1. Regional Dashboard
5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
5.3. North America
5.3.1. U.S.
5.3.1.1. Key country dynamics
5.3.1.2. Regulatory framework/ reimbursement structure
5.3.1.3. Competitive scenario
5.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. Canada
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Mexico
5.3.3.1. Key country dynamics
5.3.3.2. Regulatory framework/ reimbursement structure
5.3.3.3. Competitive scenario
5.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Germany
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. France
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Italy
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.6. Norway
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.3. India
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.4. Australia
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
5.6.2. Argentina
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
5.7.3. UAE
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
5.7.4. Kuwait
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.2.2. Key customers
6.2.3. Key company market share analysis, 2024
6.2.4. GE Healthcare
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Koninklijke Phillips N.V.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Canon
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Siemens Healthineers AG
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Ziehm Imaging GmbH
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Esaote SPA
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Hitachi Medical Corporation
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. SAMSUNG
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. FUJIFILM Holdings Corporation
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
Table 3 North America Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 4 US Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 5 Canada Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 6 Mexico Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 7 Europe Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
Table 8 Europe Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 9 Germany Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 10 UK Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 11 France Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 12 Italy Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 13 Spain Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 14 Denmark Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 15 Sweden Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 16 Norway Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 17 Asia Pacific Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
Table 18 Asia Pacific Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 19 China Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 20 Japan Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 21 India Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 22 South Korea Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 23 Australia Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 24 Thailand Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 25 Latin America Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
Table 26 Latin America Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 27 Brazil Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 28 Argentina Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 29 MEA Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
Table 30 MEA Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 31 South Africa Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 33 UAE Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
Table 34 Kuwait Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Coronary heart disease diagnostic imaging devices market: market outlook
Fig. 14 Coronary heart disease diagnostic imaging devices competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Coronary heart disease diagnostic imaging devices market driver impact
Fig. 18 Coronary heart disease diagnostic imaging devices market restraint impact
Fig. 19 Coronary heart disease diagnostic imaging devices market: Modality movement analysis
Fig. 20 Coronary heart disease diagnostic imaging devices market: Modality outlook and key takeaways
Fig. 21 Computed Tomography market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 X rays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Nuclear medicine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Global Coronary heart disease diagnostic imaging devices market: Regional movement analysis
Fig. 27 Global Coronary heart disease diagnostic imaging devices market: Regional outlook and key takeaways
Fig. 28 Global Coronary heart disease diagnostic imaging devices market share and leading players
Fig. 29 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 US key country dynamics
Fig. 31 US market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Canada key country dynamics
Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Mexico key country dynamics
Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 UK key country dynamics
Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Germany key country dynamics
Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 France key country dynamics
Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Italy key country dynamics
Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Spain key country dynamics
Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Denmark key country dynamics
Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Sweden key country dynamics
Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Norway key country dynamics
Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 China key country dynamics
Fig. 55 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Japan key country dynamics
Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 India key country dynamics
Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Thailand key country dynamics
Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 South Korea key country dynamics
Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Australia key country dynamics
Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Brazil key country dynamics
Fig. 68 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Argentina key country dynamics
Fig. 70 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 South Africa key country dynamics
Fig. 73 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia key country dynamics
Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 UAE key country dynamics
Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Kuwait key country dynamics
Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Market share of key market players- Coronary heart disease diagnostic imaging devices market

Companies Mentioned

  • Canon
  • Esaote SPA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Koninkilijhe Phillips N.V.
  • SAMSUNG
  • Siemens Healthineers AG
  • Ziehm Imaging GmbH

Methodology

Loading
LOADING...

Table Information